Completed
Pegfilgrastim PBPC Mobilization Study
NCT00066092
- Conditions
- Hematology, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,476 public trials
175 recruiting studies
Lymphoma trial results
NCT00536393
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Clinique Victor Hugo Le Mans, France
NCT00320827
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00136552
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium
- Hôpital Henri Mondor Créteil, France
- Hôpital Saint Louis Paris, France
- Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France
NCT00086034
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- San Diego, California, United States
- Stanford, California, United States
- Miami, Florida, United States
- Chicago, Illinois, United States
Completed
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
NCT00299780
- Conditions
- Acute Myelogenous Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
Completed
Dose Reduction in Thoracic CT
NCT00188461
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
NCT00001579
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
NCT00035022
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Ultrasound Biomicroscopy - Apoptosis
NCT00188370
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +20 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada